PET in lymphoma.
This review attempts to discuss the role of positron emission tomography (PET) imaging for staging, treatment response and follow-up of patients with lymphoma. The pitfalls and impact of PET imaging on the clinical management are also addressed.
Collins
Conor D
CD
St Vincent's University Hospital, Dublin, Ireland. c.collins@st-vincents.ie
D001853:Bone Marrow / Q000000981:diagnostic imaging / Q000473:pathology; D019090:Case Management; D005500:Follow-Up Studies; D006801:Humans; D008198:Lymph Nodes / Q000000981:diagnostic imaging / Q000473:pathology; D008223:Lymphoma / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000473:pathology; D009367:Neoplasm Staging / Q000379:methods; D018365:Neoplasm, Residual; D049268:Positron-Emission Tomography; D011237:Predictive Value of Tests; D047368:Tumor Burden